Randomised Non-Inferiority Trial
Cross-source consensus on Randomised Non-Inferiority Trial from 1 sources and 5 claims.
1 sources · 5 claims
Comparisons
Other
Other
Other
Other
Highlighted claims
- The study is a single-centre, randomised, parallel-controlled, double-blind, non-inferiority clinical trial. — Liposomal bupivacaine versus standard ropivacaine for pain control in adults receiving continuous supraclavicular brachial plexus blocks for open elbow arthrolysis: study protocol for a randomised controlled non-inferiority clinical trial
- The trial is registered in the Chinese Clinical Trial Registry as ChiCTR2500103911. — Liposomal bupivacaine versus standard ropivacaine for pain control in adults receiving continuous supraclavicular brachial plexus blocks for open elbow arthrolysis: study protocol for a randomised controlled non-inferiority clinical trial
- The study plans to enroll 72 participants after accounting for anticipated dropout. — Liposomal bupivacaine versus standard ropivacaine for pain control in adults receiving continuous supraclavicular brachial plexus blocks for open elbow arthrolysis: study protocol for a randomised controlled non-inferiority clinical trial
- The primary aim is to determine whether single-shot liposomal bupivacaine is equivalent to continuous ropivacaine for postoperative analgesia in adults undergoing open elbow arthrolysis. — Liposomal bupivacaine versus standard ropivacaine for pain control in adults receiving continuous supraclavicular brachial plexus blocks for open elbow arthrolysis: study protocol for a randomised controlled non-inferiority clinical trial
- Randomisation uses a 1:1 block-randomised allocation generated by an independent statistician using SAS V.9.0. — Liposomal bupivacaine versus standard ropivacaine for pain control in adults receiving continuous supraclavicular brachial plexus blocks for open elbow arthrolysis: study protocol for a randomised controlled non-inferiority clinical trial